Rep/cap plasmids are essential components of the AAV genome and are required for the production of recombinant AAV.
The research grade product, pALD-AAV6 is immediately available at the good manufacturing practice (GMP) source quality level, while pALD-AAV2 and pALD-AAV5 will be made available based on market demand. These products are designed to support preclinical activities through clinical development and commercial production, according to Aldevron.
"Along with offering catalog items, we have increased capacity and reduced lead times, providing us the ability to scale while meeting important client deadlines," Michelle Berg, president of Aldevron's GMP nucleic acids business unit.
Copyright © 2021 scienceboard.net